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ABSTRACT 41 
 42 
The Arp2/3 complex is an evolutionary conserved molecular machine that generates branched 43 
actin networks. When activated, the Arp2/3 complex contributes the actin branched junction 44 
and thus cross-links the polymerizing actin filaments in a network that exerts a pushing force. 45 
The different activators initiate branched actin networks at the cytosolic surface of different 46 
cellular membranes in order to promote their protrusion, movement or scission in cell 47 
migration and membrane traffic. Here we review the structure, function and regulation of all 48 
the direct regulators of the Arp2/3 complex that induce or inhibit the initiation of a branched 49 
actin network and that controls the stability of its branched junctions. Our goal is to present 50 
recent findings concerning novel inhibitory proteins or the regulation of the actin branched 51 
junction and place these in the context of what was previously known in order to provide a 52 
global overview of how the Arp2/3 complex is regulated in human cells. We focus on the 53 
human set of Arp2/3 regulators to compare normal Arp2/3 regulation in untransformed cells 54 
to the deregulation of the Arp2/3 system observed in patients affected by various cancers. In 55 
many cases, these deregulations promote cancer progression and have a direct impact on 56 
patient survival. 57 
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I. INTRODUCTION 82 
 83 
The Arp2/3 complex is a major actin nucleating molecular machine, which is conserved 84 
in eukaryotes. This is the only molecular machine that generates branched actin networks. 85 
The Arp2/3 complex was first discovered as a multiprotein complex containing actin-related 86 
proteins (160) and rediscovered as an actin nucleating machine (270). Ever since, the Arp2/3 87 
complex has been associated with many functions, which we review here as we describe the 88 
regulators of Arp2/3 activity. A flurry of recent papers have reported novel regulators of the 89 
Arp2/3 complex, with, for example, several inhibitory proteins or regulators of the actin 90 
branched junction. The major goal of this review is to integrate these new findings into 91 
established knowledge of Arp2/3 regulation in order to provide a global overview of the 92 
Arp2/3 regulatory system.  93 
The reader can directly focus on his or her molecule of interest, which are classified 94 
according to the type of regulation they provide to the Arp2/3 complex (Fig.1). The 95 
monograph of each regulator is structured to describe, in this order, its molecular structure, its 96 
main cellular function, and then how it is regulated in the normal mammalian cell and 97 
deregulated in the cancer cell. We believe that this review organization can help the 98 
newcomer to enter in this profuse field.  99 
Deregulation of the Arp2/3 regulatory system in cancer has been described over the 100 
years. Examination of all these examples highlights the fact that over activation of the Arp2/3 101 
complex generally promotes cancer progression (Table 1). However, we will also describe 102 
notable exceptions, and attempt to provide an explanation as to why these anomalies still lead 103 
to cancer. The topic of the Arp2/3 complex and cancer has been less frequently covered than 104 
the hijacking of the Arp2/3 complex by pathogens, which has been nicely reviewed recently 105 
(271), and will not be addressed here. This topic also justifies focusing on the human genes 106 
and gene products, and hence to use the consensus human nomenclature to describe their 107 
activities. 108 
 109 
II. THE ARP2/3 COMPLEX 110 
 111 
A. The canonical Arp2/3 complex 112 
 113 
The Arp2/3 complex is a stable multiprotein complex of 7 subunits, with a total mass of 114 
about 250 kDa. Two of these subunits are Actin related proteins, Arp2 and Arp3. The crystal 115 
structure of the complex has revealed an inactive conformation, where Arp2 and Arp3 are 116 
maintained far apart in the architecture provided by the 5 other subunits, named ARPC1 to 5 117 
(Fig.1) (200). The Arp2/3 complex creates branched actin networks (16). In the active 118 
conformation, the Arp2/3 complex contributes a branched junction of two actin filaments, 119 
whose structure was revealed by electron microscopy (208, 257). This active conformation 120 
involves bringing together Arp2 and Arp3 within the complex, so that these two subunits 121 
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adopt the conformation of actin molecules within a filament (Fig.1). This conformation, 122 
however, can also be detected in a population of soluble Arp2/3 complexes, in the absence of 123 
any actin. The population of Arp2/3 complexes displaying the active conformation is greatly 124 
increased by Nucleation Promoting Factors (NPFs), such as N-WASP or WAVE (82, 203). 125 
The conformationally activated Arp2/3 complex can then interact with a pre-existing actin 126 
filament, often referred to as the mother filament, in order to initiate the elongation of a lateral 127 
branch, the daughter actin filament (204). The widely used Arp2/3 inhibitory compound, CK-128 
666, binds Arp2 and Arp3 and blocks their conformational rearrangement that is required for 129 
Arp2/3 activation (13, 95). 130 
The function of the Arp2/3 complex is to induce an explosive actin polymerization in 131 
response to signaling pathways. Because actin filaments are both substrates (mother) and 132 
products (daughter) of the branching reaction, the process has been described as autocatalytic 133 
and indeed generates an exponential increase of actin filaments (2). The resulting branched 134 
actin networks, also referred to as dendritic actin networks, have been demonstrated to 135 
generate a pushing force in vitro (153, 292). In the cell, the various NPFs are anchored at the 136 
surface of different membranes and the force they generate through the generation of 137 
branched actin networks remodel these membranes to perform various cellular functions. For 138 
example, the pushing force of branched actin networks allows the plasma membrane to 139 
protrude in fan-like migration structures called lamellipodia (241) and to promote scission of 140 
clathrin coated pits during endocytosis (42, 61). 141 
 142 
B. Novel complexities in the Arp2/3 complex 143 
 144 
Further complexity has recently been added to this general scheme. In the human 145 
genome, the ARPC1 subunit is encoded by two paralogous genes, ARPC1A and ARPC1B, 146 
and the ARPC5 subunit by ARPC5 and ARPC5L. The complexes containing ARPC1B or 147 
ARPC5L promote actin polymerization more efficiently than the ones containing the 148 
alternative paralogous subunits (1). The Arp2/3 activity is also regulated by phosphorylation 149 
of its subunits (140, 169). The phosphorylation of Arp2 by the serine threonine protein kinase 150 
NIK is required for the Arp2/3 activity (141). We are probably only starting to decipher this 151 
complex Arp2/3 regulation through phosphorylations. 152 
Strikingly, even the most fundamental property of the Arp2/3 complex, i.e. its ability to 153 
generate branched actin networks, has recently been found to admit exceptions. SPIN90, a 154 
protein of the WISH/Dip1 family with a conserved role in endocytosis (14, 126, 185), has 155 
been shown to induce actin polymerization without the need of a pre-existing filament. The 156 
SPIN90-Arp2/3 complex is in the active conformation and allows direct actin elongation from 157 
the rearranged Arp2-Arp3 template (258). Such a process normally does not take place with 158 
regular NPFs, since the NPF needs to dissociate from the rearranged Arp2/3 complex and the 159 
activated Arp2/3 needs to bind to a preexisting mother actin filament, in order to elongate an 160 
actin filament from the rearranged Arp2/3 (224). Linear actin filaments are also likely 161 
nucleated by hybrid complexes containing some, but not all, subunits of the Arp2/3 complex. 162 
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These hybrid complexes contain Arp2 and Arp3, which template actin filaments, but lack 163 
ARPC1, ARPC4 and ARPC5, which mediate many contacts with the mother filament (37). 164 
The hybrid complexes contain vinculin or vinculin and α-actinin, which target these 165 
hybrid Arp2/3 complexes to focal adhesions (37). A previously reported interaction between 166 
vinculin and the Arp2/3 complex probably reflects these hybrid complexes rather than 167 
vinculin transiently interacting with the whole Arp2/3 complex (49). It is likely that these 168 
hybrid complexes contribute to actin polymerization at focal adhesions. However, 169 
understanding the role of hybrid Arp2/3 complexes awaits specific ways to inhibit their 170 
assembly in the cell, given that their constituent subunits are either subunits of the Arp2/3 171 
complex or structural components of focal adhesions. Similarly, studying the molecular 172 
mechanism, by which these hybrid complexes generate linear actin filaments, awaits their 173 
purification, which is likely to be challenging given their low abundance. Moreover, 174 
reconstitution of the activity of hybrid Arp2/3 complexes may require elaborate in vitro 175 
systems, to reproduce the mechanosensitive behavior of vinculin in focal adhesions (38, 78). 176 
 177 
C. The Arp2/3 complex in cancer 178 
 179 
Arp2/3 subunits have been found by immunohistochemistry to be overexpressed in a 180 
variety of cancers, including lung (216), breast (109), gliomas (152), gastric (303) and 181 
colorectal cancers (110, 189). Since the Arp2/3 subunits assemble into a complex, the 182 
presence of one subunit is likely indicative of the whole complex. For example, similar 183 
staining were obtained with Arp2 and Arp3 antibodies in serial sections (189). However, a 184 
free pool of ARPC1B with a role in centrosomal homeostasis has also been reported (177). 185 
Three publications reported simultaneous overexpression of Arp2 and of one of its NPFs, 186 
WAVE2, in the same discrete cells of lung carcinomas (216), of breast carcinomas (109) and 187 
of colorectal carcinomas (110), indicating that, within tumors, which are often heterogeneous, 188 
overexpression of both the Arp2/3 complex and of WAVE2 corresponds to a coordinated 189 
program. Double positive cells were frequent at the invading front of breast and colorectal 190 
carcinomas (109, 110). 191 
In breast cancer cell lines and in mammary tumors obtained in a mouse model, the 192 
invasive carcinoma cells were found to overexpress genes encoding Arp2/3 subunits (261, 193 
262). In physiological 3D migrations of cancer cells, either reconstituted in vitro, or through 194 
intravital imaging in the grafted animal, protrusions along extracellular matrix fibers are more 195 
elongated than the typical fan-shaped lamellipodia observed in 2D cultures, but they 196 
nevertheless require the Arp2/3 complex (80, 261, 262, 286). Arp2/3 overexpression is tightly 197 
associated with cancer progression and tumor cell invasion. In patient biopsies, the 198 
overexpression of the Arp2/3 complex was more pronounced in high grade invasive colorectal 199 
carcinomas and was predictive of liver metastasis (110, 189). Arp2/3 mediated migration of 200 
colorectal carcinoma cells is not only important to seed metastases, but also to ensure their 201 
tumor growth through the co-optation of pre-existing blood vessels (67). Arp2/3 202 
overexpression was associated with poor patient survival in lung (216) and breast cancers 203 
(109). Arp2/3 overexpression in breast cancer is associated with HER2 overexpression, and, 204 
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in breast carcinoma cell lines that overexpress HER2, the therapeutic monoclonal antibody 205 
trastuzumab, which inhibits HER2 signaling, blocks lamellipodia formation and tumor cell 206 
invasion (294).  207 
Other very invasive cancers exhibit Arp2/3 overexpression. Arp2/3 overexpression is a  208 
marker, out of a set of only 5, used to distinguish malignant melanomas from benign nevi 209 
(119). In pancreatic cancer, the two genes encoding the two paralogous ARPC1 subunits are 210 
overexpressed (138). These two genes are localized in the 7q21-q22 region, which is 211 
frequently amplified in this cancer (138). As in other cell models, it was verified in pancreatic 212 
cancer cell lines that RNAi mediated depletion of the Arp2/3 complex decreases migration 213 
and invasion (199). 214 
For a stable multiprotein complex like the Arp2/3 complex, overexpression of one 215 
subunit at the mRNA level may not be sufficient to produce more complex. Levels of 216 
expression of most subunits are not limiting and subunits that are not assembled are thought 217 
to be degraded (51). In breast cancer, however, Arp2 protein, and thus the Arp2/3 complex, is 218 
correlated to the Arp2 mRNA level (110), indicating either that the level of Arp2 is limiting 219 
or that all subunits are up-regulated in a coordinated manner in order to assemble more 220 
Arp2/3 complexes. Levels of mRNA measured by quantitative PCR should systematically be 221 
complemented by immunohistochemistry, since carcinoma cells of the tumor are not always 222 
the cell type that displays the overexpression. For example, the Arp2/3 complex is also 223 
overexpressed in cancer-associated fibroblasts in colorectal cancer (189). Interestingly, 224 
overexpression in stromal cells is also associated with cancer progression toward the invasive 225 
stage of the carcinoma cells, in a cross-talk between stromal and carcinoma cells. 226 
 227 
III. THE NUCLEATION PROMOTING FACTORS 228 
 229 
Arp2/3 activators are called Nucleation Promoting Factors, or NPFs in short. They are 230 
characterized by their C-terminal domain that contains three short peptide motifs, a WH2, a 231 
Connector motif, and an Acidic end, in this order (Fig.2). This characteristic C-terminus is 232 
referred to as the WCA, or sometimes VCA for historical reasons. The CA binds to the 233 
Arp2/3 complex and induces its conformational activation. The WH2 motif binds to one 234 
globular actin molecule and delivers it to the rearranged Arp2/3. Both events are required to 235 
initiate an actin branch (193). In NPFs, there are sometimes more than one WH2 motif. The 236 
N-terminus vary considerably between NPFs. The N-terminus has a regulatory role. It 237 
determines how the WCA, the Arp2/3 activatory region, is masked in an inactive 238 
conformation at resting state, and how, in response to activatory signals, the WCA is going to 239 
be exposed to activate the Arp2/3 complex.  240 
The domains present in the N-terminus define the different families of NPFs (Fig.2), 241 
which activate the Arp2/3 complex at various subcellular functions to perform different 242 
functions. There are 4 families of NPFs in the human genome, WAVE, N-WASP, WASH and 243 
WHAMM families. 244 
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 245 
A. The WAVE family 246 
 247 
The WAVE family of NPFs consists of 3 WAVE proteins, sometimes also referred to as 248 
Scar proteins. WAVE2 is the ubiquitous one, WAVE1 and 3 being more restricted in their 249 
tissue expression (234). All WAVE proteins are embedded into a stable multiprotein complex, 250 
also containing ABI, CYFIP, NAP1 and BRK1 for a total of 5 subunits (58, 76, 107, 230, 251 
231). All of them, except BRK1, are encoded by paralogous genes yielding to a combinatorial 252 
complexity in the assembly of WAVE complexes (51). Moreover, some subunits, like ABI1, 253 
are alternatively spliced. Functional specializations of isoforms have been demonstrated in a 254 
couple of cases (57, 236). The WAVE1 complex has been crystallized (36). The output WCA 255 
domain is masked by its interaction with other subunits of the complex. The small GTPase 256 
Rac, the most established activator of the WAVE complex, interacts with the CYFIP1 subunit 257 
and releases the masked WCA (36, 51). 258 
The WAVE complex localizes at the edge of lamellipodia, where new actin molecules 259 
incorporate into dense branched actin networks beneath the plasma membrane (88, 136, 232). 260 
The WAVE complex localizes to the plasma membrane through its interaction with the 261 
phospholipid PIP3 or with membrane receptors (35, 186). Knock-down and knock-out 262 
experiments have established that the WAVE complex is a critical Rac effector for 263 
lamellipodium formation (171, 229, 230, 289, 290) (Fig.3). In addition to Rac, many 264 
phosphorylations are important to control WAVE complex activity (132). The major function 265 
of the WAVE complex, downstream of the small GTPase Rac, is to control cell migration, 266 
and especially persistent directional migration (132).  267 
Protrusion of the plasma membrane appears coordinated with intracellular traffic. The 268 
clathrin heavy chain has been demonstrated to interact with the WAVE complex and to 269 
promote its activation at the lamellipodium tip in an endocytosis-independent manner (75). 270 
Clathrin-mediated endocytosis is indeed not detected in lamellipodia. In contrast, the exocyst 271 
component Exo70 favors membrane protrusion by promoting the WAVE-Arp2/3 interaction 272 
(150, 307). A shut-down in endocytosis and an activation of exocytosis contribute an excess 273 
of membrane, and thus a release of membrane tension. Such a drop in membrane tension 274 
rapidly induces actin polymerization, formation of a lamellipodium and restoration of 275 
membrane tension (101, 146, 147, 198). 276 
In fibroblasts, the Rac—WAVE—Arp2/3 pathway is critical for haptotaxis, i.e. 277 
migration up a gradient of immobilized fibronectin, in line with the fact that lamellipodia are 278 
adherent membrane protrusions (127, 273). Whether this pathway is also involved in 279 
chemotaxis is controversial (240, 273). In epithelial cells, the Rac—WAVE—Arp2/3 pathway 280 
has also been involved in the formation and maintenance of cell-cell junctions (256, 288). 281 
Branched actin networks are prerequisites for the development of junctional tension through 282 
myosin contractility (255). Neogenin is a transmembrane protein of the junction that directly 283 
recruits the WAVE complex and promotes its activation by Rac at the junction (142). 284 
Through the interplay between lamellipodia and cell-cell junctions, the WAVE complex 285 
regulates collective migration of epithelial cells (181).   286 
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In transformed cells of human origin, lamellipodia are usually less prominent than in 287 
untransformed cells (Fig.4). Nonetheless, many reports indicate an important role of the 288 
WAVE complex in cell migration and tumor cell invasion. In breast invasive cell lines, for 289 
example, WAVE3 is required for lamellipodium formation and cell invasion through 290 
transwell filters (227). These in vitro results were however challenged (228). It is most of the 291 
time unclear where discrepancies come from. The extreme plasticity of tumor cell migration, 292 
where the Rac—WAVE—Arp2/3 contributes only the so-called mesenchymal migration is 293 
probably part of the explanation (6, 210). HER2 overexpression induces WAVE2 and 294 
WAVE3 expression (248, 294). WAVE3 is stabilized within the WAVE complex and 295 
destabilizing the complex with peptides forming interfaces between subunits results in 296 
reduced invasion of carcinoma cell lines in vitro (247, 249). WAVE3 depletion reduced the 297 
ability of breast carcinoma cell lines to generate lung metastasis in experiments, where 298 
genetically modified cell lines were grafted into immunocompromised mice (243, 248).  299 
In cancer, components of the WAVE complex are overexpressed and this 300 
overexpression is associated with poor patient prognosis (Table 1). All 3 WAVE proteins 301 
were found to be overexpressed in carcinomas of various origins, of the breast (62, 109, 135), 302 
of the colon (110, 302), of the liver (111, 291), of the lung (216), of the ovary (299), of the 303 
prostate (63, 64). In all these cases, but one, the overexpression of WAVE proteins is 304 
associated with reduced survival and prognosis markers of poor survival, such as high grade, 305 
lymph node invasion and metastases. The only exception is a study, which reports that 306 
WAVE3 overexpression is associated with better prognosis and better markers in colorectal 307 
carcinomas (302). This is in stark contrast to the overexpression of WAVE3 in breast and 308 
liver carcinomas, which is a predictor of poor outcome (111, 135). 309 
Similarly, for the other WAVE complex subunits, the general trend is an overexpression 310 
associated with decreased survival. This was reported for NAP1 in breast carcinomas (154), 311 
for its hematopoietic homologue HEM1 in leukemia (115), for ABI1 in breast and ovary 312 
carcinomas (259, 298). In lung carcinomas, the overexpression of the small subunit BRK1 is 313 
also associated with markers of poor prognosis, such as lymph node invasion and high grade 314 
(27). The BRK1 gene is located next to the tumor suppressor gene VHL. Large deletions that 315 
affect BRK1 at the same time as the VHL tumor suppressor protect patients from developing 316 
renal cell carcinomas, emphasizing the importance of the WAVE complex for cancer 317 
progression (60).  318 
However, two studies contradict this trend. The first one is the report of loss-of-function 319 
mutations of ABI1 in prostate cancer (283). This observation is supported by the appearance 320 
of prostate neoplasia in conditional ABI1 knock-out mice in the same study. The second study 321 
at odds with the general trend is the report of CYFIP1 downregulation in multiple carcinomas 322 
including breast, lung and colon cancers (221). Using mice engraftments with genetically 323 
modified cell lines, this study shows that CYFIP1 suppresses tumor invasion, rather than 324 
promotes it, as one could expect from the majority of cancer studies. Despite the causal 325 
relationships that these mouse models provide, it must be stressed that the importance of these 326 
two studies have not yet been confirmed with retrospective cohorts of patients.  327 
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There are 36 ways to assemble pentameric WAVE complexes with the 11 genes that 328 
encode subunits. It is likely that all paralogous genes do not encode equivalent subunits in 329 
terms of activity or regulation. It is also likely that functional specializations are only manifest 330 
in some, but not all, tissues. What remains to be established, however, is whether the few 331 
studies at odd with all the others reveal that a few specific compositions of WAVE complexes 332 
inhibit, rather than activate, actin polymerization and cell migration. 333 
 334 
 335 
B. The N-WASP family 336 
 337 
The WASP family is composed of two paralogous proteins in the human genome, the 338 
ubiquitous N-WASP and the hematopoietic WASP. N-WASP is auto-inhibited, since its 339 
WCA domain is masked by its own N-terminal WH1 domain (124). Even though this 340 
autoinhibition can be observed with N-WASP alone, N-WASP is normally complexed to one 341 
of the WIP family proteins and this heterodimeric complex is more tightly autoinhibited than 342 
N-WASP in isolation (51, 96, 97). The WIP family contains WICH and CR16 in addition to 343 
WIP. The small GTPase Cdc42 is the best characterized activator of N-WASP in vitro (51). 344 
To activate the N-WASP/WIP complex, however, the Cdc42 signal must be transduced 345 
through proteins of the (TOCA1, FBP17, CIP4) family, which contain a F-BAR domain (96) 346 
and a binding site for active Cdc42. N-WASP binds to both Cdc42 and these F-BAR 347 
containing proteins. 348 
The major functions of N-WASP are at the plasma membrane, like the WAVE complex. 349 
However, in untransformed cells, the contribution of N-WASP to membrane protrusions 350 
appears limited, despite clear Cdc42 activation at the leading edge (182). The N-WASP 351 
knock-out fibroblasts generate normal lamellipodia and filopodia (155, 225). When N-WASP 352 
was directly compared to WAVE2, both proteins were found enriched at the leading edge 353 
protrusions, but RNAi mediated depletion of WAVE2 yielded a more severe migration defect 354 
than N-WASP depletion (122). In fact, the role of N-WASP might be restricted to early 355 
adhesions to the extracellular matrix, as it is best revealed in cell spreading assays. N-WASP 356 
is important for adhesion to fibronectin and to the development of vinculin positive focal 357 
adhesions (173). Upon cell spreading, N-WASP enters in a complex with the Focal Adhesion 358 
Kinase, FAK (300). FAK also directly binds to the Arp2/3 complex through its FERM 359 
domain (217). In vitro, the FERM domain of FAK potentiates the actin polymerization 360 
induced by the Arp2/3 complex and the WCA domain of N-WASP. N-WASP stability 361 
requires both the formation of its native complex with WIP and β1 integrin (128). Indeed, 362 
upon β1 integrin depletion, N-WASP is destabilized and its proteasomal degradation can be 363 
rescued by WIP overexpression. However, after an early involvement of the Cdc42—N-364 
WASP pathway, lamellipodia seem rather to depend on the Rac—WAVE pathway. 365 
The most conserved role of N-WASP at the plasma membrane is during endocytosis 366 
(246, 268). N-WASP, but not WAVE, is specifically detected at the clathrin coated pit (15, 367 
167). N-WASP recruitment at this location relies on BAR domain containing proteins, which 368 
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induce and/or sense membrane curvature (108, 253). BAR domain containing proteins couple 369 
direct membrane remodeling with Arp2/3-mediated actin polymerization (233, 277). The 370 
force generated by branched actin networks appears to elongate the pit into a pronounced 371 
invagination and to compress the collar of the invagination (42, 61). This sequence of events 372 
promotes membrane scission, which eventually involves the GTPase dynamin. Actin 373 
polymerization and dynamin-mediated scission are intimately coupled (61, 245). 374 
Nevertheless, the role of actin polymerization in endocytosis is important, but dispensable in 375 
standard conditions (15). Actin polymerization becomes critical, when high membrane 376 
tension must be counteracted (18, 121). 377 
In transformed cells, in contrast, N-WASP becomes important to generate protrusions. 378 
In addition to lamellipodia, transformed cells generate invadopodia that degrade the 379 
extracellular matrix by localized delivery of the MT1-MMP metalloprotease (192). 380 
Invadopodia are easily recognizable ventral protrusions on 2D substrates that coexist with 381 
peripheral lamellipodia (Fig.4). They cannot be distinguished, however, from leading edge 382 
protrusions in 3D substrates. N-WASP is present and activated in invadopodia (156). 383 
Invadopodia depend on the N-WASP/WIP complex (72, 73, 176, 287). In grafted animals, 384 
breast invasive cells required N-WASP to invade, intravasate into blood circulation and to 385 
generate lung metastasis (81). Two N-WASP activators, Cdc42 and the F-BAR containing 386 
protein CIP4, are present in invadopodia and are required for tumor cell invasion (12, 191, 387 
206). This is in contrast with clathrin coated pits, which depend on F-BAR containing 388 
proteins, but not on Cdc42, and with lamellipodia, which depend on Cdc42, but not on the F-389 
BAR containing proteins. Specific upstream signaling is thus responsible for N-WASP 390 
recruitment and activation in different subcellular structures. In vitro, in 3D collagen gels, 391 
RNAi mediated depletion of the WAVE complex induces N-WASP dependent cell invasion 392 
(242), indicating a modified interplay between the two major NPFs of the plasma membrane 393 
in cancer cells compared to normal cells.  394 
In patients, N-WASP is not systematically overexpressed during cancer progression. In 395 
fact, N-WASP is overexpressed in pancreatic ductal adenocarcinomas (87), in lung cancer 396 
(68) and in hepatocellular carcinomas (114). But N-WASP displays overall normal levels in 397 
esophageal squamous cell carcinomas (263) and even down-regulation in breast carcinomas 398 
(165). In pancreatic ductal adenocarcinomas and in hepatocellular carcinomas, high N-WASP 399 
levels are associated with risk factors and decrease overall survival. In esophageal squamous 400 
cell carcinomas, despite the overall normal levels, high N-WASP, within its natural 401 
fluctuations of expression, is also associated with high grade carcinomas and lymph node 402 
invasion. Overall, as expected from its important role in invadopodia formation, N-WASP 403 
promotes cancer progression, but breast cancer appears as an exception. In breast cancer, N-404 
WASP is down regulated, instead of up regulated, and this down-regulation is associated with 405 
poor prognosis (165). Consistent with the exception of breast cancer, the N-WASP activator 406 
CIP4 is overexpressed in mammary carcinomas and associated with poor prognosis, but this 407 
effect is independent from N-WASP (206). In gliomas, the N-WASP partner WIP promotes 408 
cancer progression by stabilizing the YAP/TAZ transcription factors (74). 409 
 410 
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C. The WASH family 411 
 412 
The WASH family in the human genome displays a variable number of genes, from 15 413 
to 20 depending on individuals (149). This is due to the fact that the WASH gene is located in 414 
a subtelomeric region, which is prone to recombination. The genes were so recently 415 
duplicated, however, that, in practice, one can deplete all WASH proteins with single siRNA 416 
sequences, like any other gene product. In mice and rats, there is a single WASH gene. The 417 
WASH protein is embedded into a stable multiprotein complex (54, 83). This stable 418 
multiprotein complex is distantly related to the WAVE complex, with a one-to-one 419 
correspondence of the 5 subunits (113). Most subunits are encoded by single genes, and so the 420 
WASH complex is less diverse than the WAVE complex (52). Strikingly, however, the 421 
WASH complex recruits a pre-existing complex, which also exists on its own in the cytosol, 422 
the so-called capping protein (CP) (54). CP is in fact a heterodimer, which blocks the 423 
elongation of actin filaments. CP interaction has been shown to be important for WASH 424 
function in the amoeba Dictyostelium discoideum (190), but this is not yet understood why 425 
these two activities of actin nucleation and actin capping have to be coordinated in the same 426 
multiprotein complex. 427 
The WASH complex activates the Arp2/3 complex at the surface of endosomes (54, 428 
83). It is recruited to endosomes through its subunit FAM21, which contains multiple binding 429 
sites for the retromer (90, 93, 112). Importantly, the WASH complex and the retromer do not 430 
cover the whole surface area of endosomes, but rather define a microdomain, whose area is 431 
controlled by actin polymerization itself (53). The polymerization of branched actin is thought 432 
to promote membrane scission of transport intermediates that contain sorted receptors, in a 433 
manner similar to N-WASP during clathrin mediated endocytosis (77). The retromer performs 434 
sorting of endosomal cargoes that are either destined to follow the retrograde route to the 435 
trans-Golgi network or which are recycled to the plasma membrane (215). The WASH 436 
complex is activated through interaction with the phospholipid PI4P (56) and through 437 
ubiquitination of WASH using a K63 linkage, a modification which does not target 438 
conjugated proteins to the proteasome (89). 439 
In transformed cells, WASH promotes tumor cell invasion function through the sorting 440 
of endosomal cargoes it provides. The WASH dependent recycling of α5β1 integrins to the 441 
plasma membrane drives invasion of ovarian carcinoma cells in fibronectin containing 3D 442 
matrix (296). In breast carcinoma cells, the WASH complex interacts with the exocyst and 443 
contributes to the focal delivery of the metalloprotease MT1-MMP to invadopodia (178). This 444 
event requires transient tubular connexions between late endosomes and the plasma 445 
membrane. In cancer patient biopsies, there has been little examination of the WASH 446 
complex so far. The WASH complex subunit Strumpellin is overexpressed in high grade 447 
prostatic carcinomas, due to genetic amplification (194). 448 
 449 
D. The WHAMM family 450 
 451 
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WHAMM and JMY are two homologous proteins, which share a common modular 452 
organization (131, 254). They are composed of an amino-terminal domain, a long central α-453 
helical domain and the carboxy-terminal WCA that activates the Arp2/3 complex (120). JMY 454 
has the particularity to have 3 WH2 motifs, which bind actin. These 3 motifs were shown to 455 
be sufficient to nucleate actin in vitro in a WH2-only mechanism (305). WHAMM seems to 456 
be more expressed in epithelial tissues, such as colon, kidney and lung (29), whereas JMY is 457 
enriched in the brain, testis and lymphoid organs (3, 66). 458 
They are both localized at the Golgi, cis-Golgi for WHAMM (29), trans-Golgi for JMY 459 
(212), and they are both involved in anterograde transport, from ER to cis-Golgi and then 460 
from cis- to trans-Golgi cisternae. The role of WHAMM in trafficking involves binding of the 461 
N-terminal domain to Rab1 (209) and binding of the central α-helical domain to microtubules 462 
(219). Regulations by Rab1 and microtubules allow WHAMM to control the formation of 463 
membrane tubules, which are thought to mediate intracellular transport of anterograde cargoes 464 
(29, 209, 219). 465 
In addition, WHAMM and JMY were both recently involved in autophagy (43, 120). 466 
Their N-terminal domain dictate their localization to the ER, from which autophagosomal 467 
membranes originate. During autophagosome biogenesis, actin polymerization in a so-called 468 
'comet tail' is required to elongate membrane tubules from the ER, independently of 469 
microtubules (120). Branched actin networks also shape the autophagosome from the inside 470 
(168) and are likely involved in autophagosome closure as well. Indeed, topologically, 471 
autophagosome closure is a membrane scission event (130), and NPFs promote membrane 472 
scission, as described above for N-WASP and WASH. Connexions between Arp2/3 and 473 
autophagy appear numerous. WASH inactivation leads to massive autophagy through 474 
elucidated molecular pathways implicating the major regulators Beclin1, RNF2 and 475 
AMBRA1 (281, 282). However, the meaning of why WASH should suppress autophagy is 476 
not yet clear.  477 
 478 
E. An emerging function of NPFs in gene transcription 479 
 480 
JMY was originally identified as a cofactor for the p300/CBP transcription coactivator 481 
(220). JMY translocates to the nucleus, when actin concentration decreases in the cytoplasm 482 
and that actin does no longer bind to its cluster of WH2 motifs (304). In the nucleus, the 483 
JMY-p300 co-activator complex engages with transcription factors, such as p53 or HIF1α to 484 
induce the transcription of target genes involved in apoptosis or in cell motility (44, 45). The 485 
Arp2/3 complex and the other NPFs were also described moonlighting in the nucleus to 486 
regulate transcription. 487 
N-WASP has a marked effect on gene transcription (279). Actin, the Arp2/3 complex 488 
and N-WASP coimmunoprecipitate with the RNA polymerase II, which transcribes most 489 
protein encoding genes (279, 295). Nuclar Arp2/3 generates branched actin networks like its 490 
cytoplasmic counterpart (295). N-WASP might exert this transcription role through its 491 
interaction with the nuclear PSF/NonO complex (279). The tyrosine phosphorylation of N-492 
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WASP by Src family kinases (235) and FAK (278) favors its cytoplasmic localization at the 493 
expense of its nuclear localization and can thus downregulate its transcriptional role. The 494 
extent of the requirement of N-WASP for general gene transcription is, however, questioned 495 
by the apparent mild phenotype associated with N-WASP knock-out (155, 225). 496 
FAM21, a subunit of the WASH complex, has also been recently implicated in gene 497 
transcription (50). FAM21 shuttles back and forth in the nucleus. FAM21 regulate NF-κB 498 
transcription by binding to the p65 subunit of NF-κB and to the inhibitor of NF-κB kinases, 499 
IKKα, β and γ. This function of FAM21, however, appears relatively independent of the 500 
WASH NPF.   501 
The generation of nuclear branched actin can also derepress gene transcription through 502 
chromatin remodeling. Toca-1, one of the BAR containing activators of N-WASP, is critical 503 
to reactivate the pluripotency gene, Oct4, in nuclear reprograming experiments, where 504 
somatic nuclei are injected into Xenopus oocytes (174). The Rac—WAVE pathway is 505 
similarly required (175). In T lymphocytes, the hematopoietic WASP controls the 506 
lymphocytic Th1 differentiation program, because Th1 differentiation genes are occluded 507 
through methylation of histone H3 in patients affected by Wiskott-Aldrich syndrome, where 508 
WASP is defective (244). All together, these various experiments established that nuclear 509 
Arp2/3 and NPFs may control gene transcription through both chromatin remodeling and 510 
recruitment of the RNA polymerase II. 511 
 512 
 513 
IV. ARP2/3 INHIBITORY PROTEINS 514 
 515 
Three Arp2/3 inhibitory proteins have recently been reported. The general assumption is 516 
that an inhibitor should be diffuse in the cytosol, in order to maintain globally silent a 517 
signaling pathway that is locally activated. The surprise is that these Arp2/3 inhibitory 518 
proteins are specifically localized at the surface of specific membranes, just like the 519 
activators. There is mounting evidence that they counteract specific NPFs. 520 
 521 
A. Arpin 522 
 523 
In a bioinformatics screen for potential Arp2/3 regulators, our group identified an 524 
uncharacterized protein, which contained a typical C-terminal acidic A motif, but lacked the 525 
required WH2 motif for Arp2/3 activation. In vitro this protein binds to the Arp2/3 complex, 526 
but cannot activate it. It thus acts as a competitive inhibitor of NPFs (47) and was called 527 
Arpin as a mnemonic for Arp2/3 inhibition. There is a single Arpin gene in the human 528 
genome. In vitro Arpin constitutively exposes its C-terminal acidic tail, which inhibits the 529 
Arp2/3 complex (65). When bound to Arpin, the Arp2/3 complex is in the inactive 530 
conformation, where Arp2 and Arp3 are far apart (226). 531 
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In the cell, Arpin localizes at the lamellipodial edge, i.e. where branched actin is 532 
nucleated by the WAVE complex. Arpin's ability to interact with the Arp2/3 complex depends 533 
on Rac activity, which induces lamellipodia (47). Indeed, by single molecule imaging, Arp2/3 534 
complexes from the lamellipodial edge were not all activated and incorporated into the 535 
branched actin network that undergoes retrograde flow. Some Arp2/3 complexes were seen to 536 
move laterally in the plane of the plasma membrane (172) (Fig.3). The Arp2/3 complexes are 537 
likely maintained inactive by Arpin at this location. Arpin is an inhibitor of cell migration 538 
(84). Without Arpin, lamellipodia protrude for longer, and, as a consequence, sustain active 539 
directional migration.  540 
Consistent with an inhibitory role on cell migration, Arpin was found to be down-541 
regulated during breast cancer progression. In two independent retrospective cohorts of breast 542 
cancer patients, Arpin down-regulation, documented at both mRNA and protein levels, was 543 
associated with lymph node invasion and decreased survival (151, 154). The most powerful 544 
prognosis factor, however, is obtained when patients having tumors displaying Arpin down-545 
regulation are combined with patients having tumors displaying up-regulation of the WAVE 546 
complex (154). Patient analyses thus confirm the specific antagonism between Arpin and the 547 
WAVE complex deduced from the analyses of cell migration in vitro. 548 
 549 
B. Gadkin 550 
 551 
Gadkin, also known as γ-BAR, is another protein that interacts with the Arp2/3 complex 552 
through an acidic motif (163). The AP1AR gene, which encodes Gadkin, has no paralog in 553 
the human genome. Gadkin localizes at steady state at the surface of endosomes (213). 554 
Gadkin regulates the trans Golgi network—endosomal traffic by entering in a complex with 555 
the kinesin KIF5 and the clathrin adaptor AP-1 (213). Its function and localization are thus 556 
most similar to the ones of the WASH complex among the different NPFs. In Gadkin knock-557 
out cells, the Arp2/3 complex associated with endosomes appear to polymerize more F-actin 558 
(211). It is thus logical to assume that Gadkin maintains the Arp2/3 complex in an inhibited 559 
conformation, like Arpin. However, in in vitro assays of Arp2/3 activity, purified Gadkin does 560 
not inhibit actin nucleation (163), suggesting that Gadkin's activity is not yet properly 561 
reconstituted in such in vitro assays. It is tempting to speculate that Gadkin might antagonize 562 
the WASH complex at the surface of endosomes, but this hypothesis awaits the demonstration 563 
that they both regulate the endosomal sorting of the same receptors.  564 
Gadkin has been shown to be overexpressed in breast cancer, but this overexpression is 565 
not associated with patient prognosis (154). 566 
 567 
C. PICK1 568 
 569 
PICK1 is a protein containing a PDZ and a BAR domain. PICK1 is encoded by a single 570 
gene, which is ubiquitously expressed with an enrichment in the brain (144). The PDZ 571 
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domain of PICK1 connects it to numerous membrane receptors and transporters, the most 572 
studied of which is the AMPA receptor of the glutamate neurotransmitter. The BAR domain 573 
dimerizes and induces or senses curved membranes through its banana-shaped membrane 574 
binding interface (161, 233). The C-terminal part of the molecule contains an acidic motif that 575 
binds and inhibits the Arp2/3 complex (202). This inhibitory activity was reported to be 576 
regulated by the GTPase Arf1 (201). 577 
PICK1 regulates AMPA receptor trafficking, and in particular its clathrin-dependent 578 
endocytosis (9, 202). The role of PICK1 is thus most consistent with an antagonism with N-579 
WASP at the clathrin coated pits. However, the situation is more complex than previously 580 
thought, since the BAR domain of PICK1 recognize mostly vesicles derived from the trans 581 
Golgi network and inhibition of the Arp2/3 complex in vitro was not reproduced in a recent 582 
study (161). PICK1 regulates long-term depression and long-term potentiation of synapses 583 
(125, 201, 250). These effects are mediated by expansion or contraction of post-synaptic 584 
structures called dendritic spines. Dendritic spines are actin-rich membrane structures, 585 
perhaps equivalent to a mini-lamellipodium except that filaments emanating from a central 586 
branched actin network are laterally elongated, thus allowing the expansion of the spine (33). 587 
Like in the lamellipodium, the central branched actin network is nucleated by the Rac—588 
WAVE—Arp2/3 pathway (34). PICK1 controls the activity-regulated size of dendritic spines 589 
(8). Consistent with an inhibitory role, PICK1 depletion expand spines, whereas its 590 
overexpression induce spine shrinkage (180). In glial cells, PICK1 might antagonize WAVE 591 
rather than N-WASP, because PICK1 depletion increases branching complexity of astrocytes, 592 
whereas WAVE2 depletion decreases it, unlike N-WASP depletion (179). 593 
In cancer as well, the role of PICK1 is complex. In gliomas, PICK1 expression is down-594 
regulated in aggressive astrocytic tumors (41). In contrast, in the breast, PICK1 was reported 595 
to be overexpressed in tumors of poor prognosis (297). PICK1 overexpression in breast 596 
cancer was, however, not observed in a second independent cohort (154). 597 
 598 
V. BRANCH REGULATORS 599 
 600 
A. Cortactin 601 
 602 
The cortactin family is composed of two members, the ubiquitous cortactin protein and 603 
HS1, which is hematopoietic-specific and thus less studied. Cortactin interacts with actin 604 
filaments through its specific cortactin repeats and with the Arp2/3 complex through an acidic 605 
motif, which has the particularity to be located in the N-terminus of the protein (Fig.5). 606 
Cortactin was previously proposed to be a NPF, because it does activate the Arp2/3 complex 607 
in vitro at high concentration. However, cortactin strongly synergizes with NPFs, because it 608 
acts after WCA induced branching nucleation by inhibiting debranching (265, 266). Cortactin 609 
thus competes for Arp2/3 binding with the NPF and by doing so favors NPF detachment 610 
(223). NPF detachment is a prerequisite for the elongation of a daughter filament from an 611 
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Arp2/3 complex that has landed onto a mother filament (59, 94, 224). Cortactin then remains 612 
bound to the Arp2/3 at the actin branch and prevents it from debranching (25) (Fig.6). 613 
In cells, cortactin is a good marker of branched actin networks, because it labels them 614 
all along their length and independently of their subcellular location (116, 267). In contrast, 615 
NPFs are specific for each organelle and are only localized at the interface between the 616 
organelle and the branched actin structure. By FRAP, cortactin was seen to undergo 617 
continuous exchange along the length of lamellipodial actin network (136). Further in vivo 618 
evidence that cortactin associates with Arp2/3 at the branch include double immunogold 619 
labeling of lamellipodial actin networks by electron microscopy (25). Elongation of actin 620 
filaments induces the retrograde movement of Arp2/3 complexes that have landed on a 621 
mother filament. This movement extracts the NPF from the membrane displaying it. 622 
Inactivating the Arp2/3 complex or blocking actin dynamics indeed freezes the turnover of 623 
NPFs and induces a striking accumulation of WAVE, WASP or WASH at the surface of their 624 
respective membrane (53, 172, 269). It remains to be tested, however, if cortactin 625 
overexpression prevents NPF extraction that ensures the turnover measured by FRAP. 626 
Cortactin has been discovered as a tyrosine-phosphorylated protein in cells transformed 627 
by the Src oncogene (274, 275). It has since been demonstrated to be a substrate of numerous 628 
tyrosine kinases, of both receptor and non-receptor types (19, 46, 71, 102, 118). Cortactin is 629 
also phosphorylated on serine residues by MAP kinases (28) and PAK1, the well-known 630 
effector of Rac and Cdc42 pathway (86, 92). It is not known if these modifications 631 
specifically regulate the branch regulatory function of cortactin, but it does signal to 632 
cytoskeleton regulatory proteins. Tyrosine phosphorylation controls cortactin association with 633 
cofilin and its activation (162, 188). Cortactin phosphorylation also regulates its ability to 634 
bind and activate N-WASP, through its C-terminal SH3 domain (166). Cortactin is subjected 635 
to other types of post-translational modifications, such as acetylation, which prevents its 636 
binding to actin filaments and decreases cell migration (301). 637 
Cortactin was found to promote lamellipodial persistence and cell motility in 638 
transformed cells (21, 123). However, this is likely not a direct effect of its branch stabilizing 639 
activity, but rather a signaling role of cortactin, since cortactin knock-out fibroblasts have no 640 
visible defects in lamellipodial ultrastructure and only modest alterations of migration 641 
parameters (137). Strikingly, the defects of cortactin depleted cells can be rescued by 642 
adhesion to the matrix deposited by control cells, suggesting that cortactin have defects in 643 
depositing extracellular matrix (239). Invadopodia, the major protrusions of cancer invasive 644 
cells, depend on cortactin, in addition to their specific NPF, N-WASP. Cortactin is a structural 645 
component of the branched actin networks that induce invadopodial protrusions and its 646 
activation by phosphorylation is critical for this process (10, 11, 40, 55). Intracellular traffic 647 
controls the focal secretion of the metalloproteases of the invadopodia and cortactin favors 648 
secretion, in addition to its role in creating the protrusion (10, 40, 99, 129). Exosome 649 
secretion, which is important for communication between cancer cells and between cancer 650 
cells and cancer-associated cells from their microenvironnement, critically depends on 651 
cortactin (222). 652 
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Cortactin is overexpressed in many cancers (Table 2). The CTTN gene encoding 653 
cortactin is located on the 11q13 genomic region, which is frequently amplified during cancer 654 
progression, especially in head and neck squamous cell carcinoma (HNSCC) and in breast 655 
cancer (214). In HSNCC, cortactin overexpression, due to CTTN amplification, is associated 656 
with cancer progression, invasion of lymph nodes, and recurrence (98, 205, 207). In HNSCC 657 
cell lines, cortactin overexpression promotes cell growth in vitro and tumor growth in 658 
xenografts (39, 252). Cortactin overexpression favors cell growth independent of growth 659 
factors, of anchorage and mediates resistance to contact inhibition, which are three major 660 
hallmarks of transformation. In patients, cortactin overexpression is associated with high 661 
grade tumors, metastases and poor survival in squamous cell carcinomas from the larynx, 662 
from the esophagus and from the oral cavity (7, 79, 157, 237, 285). In breast cancers, 663 
cortactin is also overexpressed, but this overexpression was consistently found not to be 664 
associated with patient prognosis (48, 104, 218). Nevertheless, in xenografts, cortactin 665 
expression enhances the ability of a breast carcinoma cell line to metastasize to the bones 666 
(143). These results are not as paradoxical as it might seem: Cortactin can be involved in the 667 
transformation process and in cancer progression, and not be associated with a poor 668 
prognosis, if the overexpression occurs most frequently in breast cancer subtypes, which are 669 
not as aggressive, as the one associated with the poorest patient survival. Cortactin 670 
overexpression has been associated with high grade tumors, but not yet with poor survival, in 671 
ovarian carcinomas (148), in non small cell carcinomas of the lung (184), in gliomas (260). 672 
Cortactin has been associated with both high grade tumors and poor survival in colorectal 673 
cancer (22, 183), in gastric cancer (264), in prostate cancer (100), in melanoma (284) and in 674 
hepatocellular carcinoma (103). 675 
 676 
B. Coronin 677 
 678 
There are 7 coronins in human, which are characterized by a so-called β-propeller 679 
structure made of WD40 repeats (31). Here we will discuss only the type I coronins, among 680 
which Coro1B and Coro1C are ubiquitous and Coro1A hematopoietic-specific. At the C-681 
terminus, a coiled-coil domain mediates homo and hetero-trimerization of coronins (117). 682 
Coronins are binding to both the Arp2/3 complex and actin filaments. In all type I coronins, a 683 
binding site for actin filaments is in the β-propeller, but Coro1C possesses a second filament 684 
binding site in a unique region (31, 32). The site binding to the Arp2/3 complex is in the N-685 
terminus of coronins. Arp2/3 binding is regulated by the phosphorylation of two serines in the 686 
N-terminus and C-terminus. Phosphomimetic mutations of these sites strongly decrease 687 
Arp2/3 binding (23, 280). 688 
In vitro, coronin enhances Arp2/3 debranching and both binding sites are required for 689 
this effect (24, 25). An antagonism between cortactin and coronin has thus been proposed to 690 
control the debranching rate of branched actin networks (25). Coronin does not stain the 691 
branched actin structures to their top where new branches are formed, indicating that coronin 692 
acts at a later stage than cortactin (25). However, one has to understand why in vivo coronin 693 
is a good marker of branched actin networks at lamellipodia, as well as at the surface of 694 
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endosomes (26, 197). If the only role of coronin was to debranch, coronin should not stay in 695 
the branched actin network. Recent data explain the conundrum that coronin remains 696 
associated with the branched actin structure that it remodels: Coronin would not have the 697 
same effect on the Arp2/3 complexes depending on their precise composition in paralogous 698 
subunits (1). The Arp2/3 complexes containing ARPC1A and/or ARPC5 would indeed be 699 
debranched by coronin, whereas the most efficient Arp2/3 complexes containing ARPC1B 700 
and/or ARPC5L would be immune to coronin-induced debranching (Fig.6). Coronin could 701 
thus mediate partial debranching of the branched actin networks and at the same time be a 702 
good marker of the branched actin structures.  703 
The serine 2 of Coronin 1B has been shown to be phosphorylated by PKCs in response 704 
to factors that induce actin polymerization and cell motility, such as platelet-derived growth 705 
factor (PDGF) or phorbol myristate acetate (PMA) (23, 272). These observations are 706 
consistent with a shut-down of Arp2/3 debranching, when branched actin networks are 707 
triggered. Depletion of coronin, however, alters lamellipodial dynamics and impairs cell 708 
migration as a consequence (26). These effects might only be partially due to Arp2/3 709 
debranching. Indeed, coronin recruits to branched actin networks the phosphatase slingshot 710 
that activates cofilin by dephosphorylation (26). Coronin, together with cofilin, promotes the 711 
disassembly of branched actin structures, when the actin filaments age (20, 69, 134). Through 712 
its activities of Arp2/3 debranching and actin disassembly, coronin appears to down-regulate, 713 
rather than promote, branched actin networks.  714 
Coronin 1C is overexpressed in gliomas (251), in hepatocellular carcinomas (276), 715 
gastric cancers (238), lymphomas (159). When it has been examined, coronin overexpression 716 
is associated with high grade tumors and poor survival for patients. It might seem at odds that 717 
a type I coronin, which globally down-regulates branched actin networks, might be 718 
overexpressed in cancers, while the Arp2/3 complex is also overexpressed. However, coronin 719 
activities in favoring debranching and actin depolymerization might be important to replenish 720 
available pools of actin molecules and Arp2/3 complexes for continuous actin polymerization 721 
and sustained cell movements (26, 272).  722 
 723 
C. GMF 724 
 725 
There are two Glia-Maturation Factors (GMF) proteins encoded in humans, GMFβ 726 
encoded by the GMFB gene and GMFγ encoded by GMFG. GMFB is expressed ubiquitously 727 
with an enrichment in the brain (91), whereas GMFG is mostly expressed in hematopoietic 728 
cells and endothelial cells (105). These two homologous proteins belong to the same 729 
superfamily as cofilin, but define a subfamily of their own (85, 196). GMFs are cofilins, 730 
which have evolved to bind to Arp2, instead of actin. GMF uses this Arp2 binding site to 731 
insert intself in between Arp2 and the actin molecule and thus severs the branch in a way 732 
similar to cofilin severing actin filaments (70, 158, 293). GMF preferentially recognizes Arp2, 733 
when it is bound to ADP (17). ATP hydrolysis by Arp2 is not required for branched actin 734 
nucleation, since it occurs after branched actin nucleation (106, 139, 164). As a consequence 735 
ATP hydrolysis by Arp2 acts as a timer, indicating that the actin branch has aged, the same 736 
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way ATP hydrolysis by the actin molecules in a filament indicates the older portion of the 737 
filament. Cofilin also severs ADP-actin filaments more efficiently than younger ATP-actin 738 
filaments (30, 170, 187). GMF binding to Arp2 is regulated by phosphorylation of its serine at 739 
position 2 (105), just like cofilin (5).  740 
It is not yet established whether coronin and GMF provide two independent means of 741 
debranching branched actin networks for increased robustness or whether they collaborate to 742 
perform efficient debranching together. GMF and coronin may play sequential roles in the 743 
molecular reaction of Arp2/3 debranching. Indeed, once GMF has severed the connexion 744 
between the Arp2/3 complex and the daughter filament, the Arp2/3 complex is still interacting 745 
with the mother actin filament and coronin has been shown to detach such landed Arp2/3 746 
complexes from filaments (25).  747 
In the cell, GMF depletion alters lamellipodial dynamics by decreasing disassembly of 748 
branched actin networks (91, 195). The consequence on cell migration is not dramatic, but 749 
can be seen in instances, where migration is finely regulated. Depletion of GMFγ from 750 
neutrophils impairs their chemotaxis towards inflammatory cytokines (4), whereas depletion 751 
of GMFβ from fibroblasts impairs their haptotaxis towards immobilized extracellular matrix 752 
(91).  753 
GMFβ is overexpressed in gliomas, because it is expressed by tumor cells and 754 
endothelial cells of new capillaries feeding the tumor (133). Endothelial cells within the 755 
glioma thus express GMFβ, instead of GMFγ for normal vessels. GMFβ overexpression in 756 
glioma-associated endothelial cells has been reported to be a better prognosis factor than 757 
GMFβ overexpression in tumor cells (133). Both GMFβ and GMFγ are overexpressed in 758 
ovarian cancers (145, 306). As we have seen for coronin, the overexpression of a branch 759 
destabilizer might promote the turnover of branched actin networks. 760 
 761 
VI. CONCLUSION 762 
 763 
In about 20 years, the Arp2/3 complex has been implicated in a variety of processes. It 764 
is now clear that the branched actin networks and the pushing force that they generate are 765 
major means that cells use to remodel their plasma membrane in cell migration as well as 766 
their internal membranes in membrane traffic. In many instances, the in vivo role of Arp2/3 767 
regulators has been reconstituted in vitro and these endeavors gave rise to in depth 768 
understanding of molecular and cellular functions of Arp2/3 regulation. To go back and forth 769 
from the molecular level in appropriate reconstitutions to the cellular level, where molecular 770 
dynamics can also be addressed using techniques such as FRAP, has allowed to identify and 771 
rule out artifactual molecular behaviors sometimes observed in vitro in conditions far from 772 
the cell physiology. 773 
Here we have attempted to organize the various Arp2/3 regulators in systems. The NPFs 774 
divide the labor of generating the diverse branched actin structures of the cell. The 775 
combinatorial complexity in assembling NPF complexes imposes to study the repertoire of 776 
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paralogous subunits expressed in each cell system. Similar complexity emerged at the level of 777 
the different Arp2/3 complexes, which might themselves be differentially regulated by the 778 
different NPF complexes. Similarly, the identification of different Arp2/3 inhibitors revealed 779 
that Arp2/3 inhibition is not global, as a means to maintain the system silent in the cytosol, 780 
but the inhibitory proteins rather balance Arp2/3 activation at the surface of different cell 781 
membranes. Similarly, regulators of the Arp2/3 branched junction fine-tune the ultrastructure 782 
of branched actin networks and their role appear mostly in highly regulated physiological 783 
processes. We begin to unravel the exquisite regulations of the Arp2/3 complex in these 784 
various situations. 785 
Deregulation of the Arp2/3 regulatory system in cancer offers an opportunity to 786 
understand its logic. If one sets aside a couple of reports at odds with the majority of 787 
publications, one can see that the Arp2/3, the WAVE and the N-WASP complexes are overall 788 
overexpressed in many cancers. These overexpressions are usually associated with poor 789 
prognosis for patients. The other NPFs more specifically involved in intracellular trafficking 790 
like WASH, WHAMM or JMY, are not, or not yet, involved in cancer progression. Down-791 
regulation of Arpin is consistent with its inhibitory role. The situation is not yet clear for 792 
Gadkin and PICK1. As for the branch regulators, the stabilizer cortactin and destabilizers, 793 
coronin and GMF, are all clearly overexpressed with an overall association with high grade of 794 
tumors and poor prognosis for the patients. These simple observations emphasize the notion 795 
that branched actin networks have to turnover fast to perform their function. The deregulation 796 
of the Arp2/3 regulatory system in cancer suggests that small molecule inhibitors of branched 797 
actin dynamics might provide a therapeutic benefit to control cancer progression. 798 
 799 
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Figure legends 803 
 804 
Figure 1: Conformations of the Arp2/3 complex and regulators of the equilibria between 805 
them. On the left, the fully inactive Arp2/3 complex displays a conformation, where Arp2 and 806 
Arp3 are far apart. On the right, the fully activated Arp2/3 complex has nucleated an actin 807 
filament from the side of a pre-existing filament. The middle conformation corresponds to a 808 
rearranged Arp2/3 complex, where Arp2 and Arp3 have been brought into proximity and 809 
mimics the end of an actin filament. This conformation allows side binding to an actin 810 
filament. Regulatory factors are represented above and below the equilibrium arrows. CK-666 811 
and CK-869 are two small molecule inhibitors of Arp2/3 activation (95), which are widely 812 
used in cell biology experiments. 813 
 814 
Figure 2: Modular organization of Arp2/3 activatory and inhibitory proteins. Their division 815 
of labor at different subcellular localizations is indicated. All activators contain a C-terminal 816 
WCA domain, which binds and activates the Arp2/3 complex, whereas all inhibitors contain 817 
an acidic motif (A), which binds to the Arp2/3 complex and competes with WCA-containing 818 
activators. When the activators were described to form a stable complex, partner subunits are 819 
depicted. An inhibitory protein that would antagonize WHAMM activatory proteins remains 820 
to be identified. SHD: Scar/WAVE homology domain; B: Basic domain; P : Proline-rich 821 
region; WH1:  WASP homology 1; CRIB: CDC42 and Rac1 Interactive Binding region; AI: 822 
Auto-Inhibition domain; WAHD1: WASH homology Domain 1; WMD: WHAMM 823 
Membrane-interacting Domain; CC : Coiled coiled; PDZ : PSD95–Dlg1–ZO1 domain; BAR: 824 
Bin–Amphiphysin–Rvs domain. 825 
 826 
Figure 3: WAVE and Arpin control the duration of branched actin polymerization at the 827 
cortex. Polymerization is triggered by Rac activation, i.e. its exchange of the bound GDP 828 
nucleotide for a GTP nucleotide. GTP-bound Rac then directly recruits the WAVE complex at 829 
the plasma membrane. Activated WAVE binds and activates several Arp2/3 complexes, 830 
which are represented with different blue intensities. Each activated Arp2/3 complex 831 
nucleates an actin branch that undergoes a retrograde movement due to actin filament 832 
elongation (white arrows). This scheme represents molecular processes in the referential of 833 
the cell membrane and not of the substratum: either the membrane is fixed and the branched 834 
actin undergoes a retrograde flow, or the branched actin structure is fixed, due to a coupling 835 
with cell adhesion structures, and the plasma membrane protrudes. Rac controls the 836 
recruitment of Arpin with a delay, after the recruitment of the WAVE complex. Arpin 837 
molecules locally bind Arp2/3 complexes and block their activation of Arp2/3 complexes. 838 
The Arp2/3 complexes, which move laterally in the plane of the plasma membrane (white 839 
arrows), are probably the ones bound to Arpin molecules. 840 
 841 
 23
Figure 4: Deregulation of the Arp2/3 regulatory system in cell transformation. In normal 842 
cells, N-WASP, WASH, WHAMM and WAVE nucleate branched actin network at the 843 
clathrin-coated pit, at the surface of endosomes, of the ER/Golgi and at the lamellipodial 844 
edge, respectively. The Arp2/3 inhibitory proteins, Arpin, Gadkin and PICK1, locally 845 
antagonize WAVE, WASH and N-WASP at their respective locations. During cell 846 
transformation, N-WASP is overexpressed and forms invadopodia. In invadopodia, WASH 847 
promotes focalized delivery of metalloproteases that degrade the extracellular matrix. In 848 
cancer cells, WAVE is overexpressed and Arpin down-regulated, despite frequent abnormal 849 
lamellipodia. Font size indicate the level of expression. 850 
 851 
Figure 5: Modular organization of proteins that regulate Arp2/3 branches. Cortactin stabilizes 852 
the Arp2/3 branches, whereas GMF and coronin destabilize them. R: cortactin Repeats; P = 853 
Proline-rich region; SH3: Src Homology 3 domain; CC = Coiled Coil ; ADF-H = ADF/cofilin 854 
Homology domain. 855 
 856 
Figure 6: Regulation of the actin junctions branched by the Arp2/3 complex. Cortactin binds 857 
the Arp2/3 complex at the branch and blocks actin debranching. GMF recognizes the Arp2/3 858 
complex in the context of the branch and severs the branch. Coronin destabilizes the actin 859 
branches formed by ArpC1A/ArpC5 containing Arp2/3 complexes. In contrast, the actin 860 
branches formed by ArpC1B/ArpC5L containing Arp2/3 complexes resist coronin's effect, 861 
thus explaining why coronin is a good marker of branched actin networks, like cortactin. 862 
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Table II: Deregulation of the Arp2/3 branch regulators in association with cancer stage and patient prognosis.
Protein name Gene name DNA mRNA Protein Cancer Overall deregulation Association with stage Survival prognosis Ref.
amplification Head and Neck ↗ lymph nodes, recurrence ↘ Rodrigo et al., 2000
amplification ✔ Head and Neck ↗ lymph nodes nd Rothschild et al., 2006
✔ Head and Neck ↗ high grade ↘ Hofman et al., 2008
✔ Larynx ↗ ↘ Gibcuset al., 2008
✔ ✔ Larynx ↗ high grade nd Ambrosio et al., 2011
✔ Esophagus ↗ high grade, metastases ↘ Lu et al., 2014
✔ Oral ↗ high grade nd Yamada et al., 2010
amplification ✔ Breast ↗ - Hui et al., 1998
amplification ✔ Breast ↗ - Dedes et al., 2010
✔ Breast ↗ - Sheen-Chen et al., 2011
✔ Colon ↗ high grade ↘ Cai et al., 2010
✔ ✔ Colon ↗ high grade ↘ Ni et al., 2015
✔ Stomach ↗ high grade, lymph nodes ↘ Wang et al., 2010
✔ Liver ↗ high grade, metastases ↘ Huang et al., 2012
✔ ✔ Brain ↗ high grade nd Wang et al., 2015
✔ Lung ↗ high grade nd Noh et al., 2013
✔ Ovary ↗ high grade nd Linet al., 2008
✔ ✔ Melanome ↗ high grade nd Xu et al., 2009
✔ Prostate ↗ high grade ↘ Hou et al., 2012
✔ Gliomas ↗ high grade nd Thal et al., 2008
✔ Liver ↗ high grade nd Wu et al., 2010
✔ Lymphoma ↗ nd Luan et al., 2010
✔ Stomach ↗ high grade ↘ Sun et al., 2014
✔ Glioma ↗ high grade, neovascularization ↘ Kuang et al., 2016
✔ Ovary ↗ high grade ↘ Li et al., 2010
GMFJ GMFG ✔ Ovary ↗ ↘ Zuo et al., 2014
nd: not determined
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